The Needles Market size in the Middle East & Africa was worth USD 329 million in 2022 and estimated to be growing at a CAGR of 7.4% to reach USD 520 million by 2027.
The increasing prevalence of chronic diseases and rising demand for vaccines are major driving factors in this region. Also, the growing geriatric population and the rising number of hospitals and clinics in the developing countries Kuwait, Saudi Arabia, and the United Arab Emirates are increasing the market for needles during the forecast period, rising research and development activities by major companies such as Johnson & Johnson, Braun Melsungen AG, and Medtronic PLC. Therefore, introducing needle technology with maximum safety and precision will most likely contribute to market growth. Furthermore, needle technology aims to lower the amount of discomfort and anxiety associated with injections.
Additionally, rising awareness regarding blood donation and testing has rapidly grown during the recent past, positively impacting the market growth. Voluntary blood donations can help fill the shortfall in blood supplies, increasing the demand for needles and syringes. Like UAE, strict rules have resulted in required blood screening tests for illnesses like HIV and HBV on donations in many industrialized locations. As a result, the usage of needles for blood donation and testing has risen dramatically in recent years. In addition, there is a strong demand for these products due to an increase in the number of sophisticated procedures requiring significant amounts of blood and blood products, such as chemotherapy, heart surgery, and organ transplant. Moreover, increasing investment and funding by the government and various private organizations in the region encourages market growth.
However, stringent government regulations and mandatory blood-screening tests on donations for infections are expected to be one of the significant market restrains in this region. In addition, a lack of awareness in underdeveloped countries is expected to impede market growth.
This research report on the Middle East & Africa Needles Market has been segmented and sub-segmented into the following categories:
By Delivery Mode:
By End User:
Geographically, the Middle East Africa needles market is expected to register notable growth during the forecast period. Increasing population is influencing the market growth. The Middle East and Africa needles market is expanding due to factors such as an increase in chronic illnesses, a rise in the incidence of cardiovascular diseases, population growth, and economic stability. The hospital segment is expected to have better during this period. The growth in the region is attributed to the healthcare sector growth and increasing out-of-pocket healthcare expenditures. Saudi Arabia and the United Arab Emirates are expected to contribute to the regional market growth. The advancement of medicine has resulted in the availability of a wide range of needles and increased specialization in the pharmaceutical industry, resulting in market expansion. Research institutes and medical device manufacturers have focused on introducing advanced needles with safety and drug delivery. Moreover, prominent market players and increasing hospitals and clinics are projected to uplift the market growth.
Companies like Becton, Dickinson and Company, B. Braun Melsungen AG, Terumo Corporation and Smiths Medical, Terumo Corporation, Smiths Medical, and Thermo Fisher Scientific are leading the Middle East & Africa Needles Market.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com